-+ 0.00%
-+ 0.00%
-+ 0.00%

Bristol-Myers Squibb Announces Promising Phase 2 Clinical Trial Results for Pumitamig in Treating Extensive-Stage Small Cell Lung Cancer

Reuters·09/08/2025 15:41:58

Please log in to view news